UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 13, 2003
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
------------------------ ------------------------------------
2000 Technology Parkway, Newark, New York 14513
-----------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
--------------
(Registrant's telephone number, including area code)
1
Item 7. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated August 13, 2003
Item 9. Regulation FD Disclosure.
The Company announced the receipt of a $2.9 million order for its lithium Thin
Cell(R) batteries from an undisclosed U. S. medical device maker. Cell
deliveries are expected to begin in September and extend into 2004. Refer to the
attached Exhibit 99.1 for the entire text of the release, which Exhibit is being
furnished but not filed in accordance with Regulation FD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: August 13, 2003 By: /s/Peter F. Comerford
----------------------------------
Peter F. Comerford
Vice President - Administration &
General Counsel
2
Index to Exhibits
(99) Additional Exhibits
99.1 Press Release dated August 13, 2003
3